Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DINUTUXIMAB BETA for Neuroblastoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 141 adverse event reports in the FDA FAERS database where DINUTUXIMAB BETA was used for Neuroblastoma.

Most Reported Side Effects for DINUTUXIMAB BETA

Side Effect Reports % Deaths Hosp.
Off label use 82 52.2% 22 7
Pyrexia 57 36.3% 2 7
Pain 46 29.3% 3 3
Death 20 12.7% 20 0
Neoplasm progression 20 12.7% 14 0
Device related bacteraemia 17 10.8% 0 0
Device related infection 16 10.2% 0 0
Diarrhoea 11 7.0% 1 1
Therapy partial responder 11 7.0% 6 0
Cough 10 6.4% 0 0
Rash 10 6.4% 1 0
Cholestasis 7 4.5% 0 7
Pruritus 7 4.5% 1 0
Acute myeloid leukaemia 6 3.8% 0 0
Alanine aminotransferase abnormal 6 3.8% 0 0

Other Indications for DINUTUXIMAB BETA

Metastases to bone marrow (27) Bone cancer metastatic (26) Neuroblastoma recurrent (13) Metastatic lymphoma (7)

Other Drugs Used for Neuroblastoma

CYCLOPHOSPHAMIDE (1,109) ETOPOSIDE (1,061) DOXORUBICIN (725) CARBOPLATIN (671) VINCRISTINE (668) CISPLATIN (633) MELPHALAN (495) TOPOTECAN (443) DINUTUXIMAB (354) BUSULFAN (252)

Related Pages

DINUTUXIMAB BETA Full Profile All Neuroblastoma Drugs DINUTUXIMAB BETA Demographics DINUTUXIMAB BETA Timeline